Scarica l'app Stockscreener
1.46
4.29%
0.06
Panoramica
Notizia
Cronologia dei prezzi
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$1.40
Aprire:
$1.42
Volume 24 ore:
465.91K
Relative Volume:
0.63
Capitalizzazione di mercato:
$29.59M
Reddito:
Utile/perdita netta:
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
1 W Prestazione:
-9.32%
1M Prestazione:
-3.31%
6M Prestazione:
-82.43%
1 anno Prestazione:
-93.33%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$1.39
$1.63
Portata 52W:
$0.9601
$42.61
SRX Global Inc Stock (SRXH) Company Profile
Nome
SRX Global Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare SRXH vs JBS, KHC, GIS, SJM, MKC.V
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SRXH
SRX Global Inc
|
1.46 | 29.59M | 0 | 0 | 0 | 0.00 |
JBS
Jbs Nv
|
12.98 | 42.70B | 88.25B | 1.91B | -681.64M | 1.6761 |
KHC
Kraft Heinz Co
|
22.27 | 26.41B | 24.99B | -5.76B | 3.95B | -4.863 |
GIS
General Mills Inc
|
32.29 | 17.27B | 18.42B | -85.30M | 1.63B | -0.1894 |
SJM
J M Smucker Co
|
119.83 | 12.80B | 9.05B | -138.70M | 1.16B | -1.307 |
MKC.V
McCormick & Company, Incorporated Voting CS
|
46.73 | 12.57B | 0 | 0 | 0 | 0.00 |
SRX Global Inc Borsa (SRXH) Ultime notizie
SRX Global Inc. (SRXH) stock price, news, quote and history - Yahoo Finance Singapore
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into Definitive Agreement to Acquire CERo Therapeutics, an Innovative Cellular Immunotherapy Company Developing CER 1236 for Hematologic Malignancies - GlobeNewswire Inc.
Three patients got a higher CER-1236 dose; no dose-limiting toxicities were observed. Results are preliminary. - Stock Titan
SRX Global and CERO 1236, a Wholly-Owned SPV, Enter into - GlobeNewswire
SRX Global Inc. entered into a Stock Purchase Agreement to acquire CERo Therapeutics, Inc. from CERo Therapeutics Holdings, Inc. for 10.8 million. - www.marketscreener.com
CERo Therapeutics to Sell Operating Subsidiary to SRX Global for $1M in Stock Plus Debt Relief - TradingView
SRX Global Allocates $1.5M to Launch Actively Managed ETFs via EMJX Platform with Kupa Inc. - Kalkine Media
SRX Global Inc. Announces Plans To Launch Family Of AI-Powered ETFs Through Its EMJX Platform - www.marketscreener.com
SRX Global Commits $1.5 Million to Launch Family of - GlobeNewswire
SRX Global commits $1.5M to launch AI-powered ETFs on EMJX, plans dividend of ETF holdings - TradingView
A planned shareholder dividend accompanies SRX Global’s (SRXH) commitment to launch active ETFs. - Stock Titan
SRX Global Company Profile & Introduction - Moomoo
SRX Global Inc. (SRXH) stock price, news, quote and history - Yahoo Finance UK
SRX Global Inc. (SRXH) Stock Price, News, Quote & History - Yahoo! Finance Canada
SRX Global Inc. (SRXH) stock price, news, quote and history - Yahoo Finance Australia
SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. - marketscreener.com
SRX Global Makes Investment in Onconetix - Yahoo Finance
A robot's eyes hold cameras. SRX Global invested in Onconetix, which has an agreement to acquire Realbotix. - Stock Titan
SRX Global Provides Shareholders with Update on Liquidation - GlobeNewswire
SRX Global Provides Shareholders with Update on Liquidation - GlobeNewswire
SRX Global Provides Shareholders With Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) - Moomoo
A robot's eyes hold cameras. SRX Global invested in Onconetix, which has an agreement to acquire Realbotix. - Stock Titan
SRX Global CEO Kent Cunningham and President of EMJX - GlobeNewswire
A free Webull account is needed to watch SRX Global's Sept. 30 webinar live. - Stock Titan
SRX Global CEO Kent Cunningham and President of EMJX Platform Eric Jackson to Present at Webull Corporate Connect Series Fintech Investment Webinar - Yahoo Finance
SRX Global (SRXH) gets holder consent to buy back up to 10M shares - Stock Titan
SRX Global Provides Shareholder Update on Portfolio Company, ARMR Sciences, a Clinical-Stage Biodefense Company - Yahoo Finance
A fentanyl vaccine produced an immune response in humans. ARMR is testing doses. - Stock Titan
SRX Global (SRXH) lines up $11.7M for CERo, backed by its cell therapy assets - Stock Titan
SRX Global Inc (SRXH) (Q3 2026) Earnings Call Highlights: Strategic EMJX Acquisition and Record ... - Yahoo Finance
SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results - GlobeNewswire
SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET - Yahoo Finance
SRX Global (SRXH) Acquires Stake in Vistagen Therapeutics - Yahoo Finance
SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN) - GlobeNewswire
SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger - GlobeNewswire
SRX Global Regains Full Compliance with NYSE American Listing Standards - Yahoo Finance
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026 - GlobeNewswire
SRX Global Board of Directors Authorizes Stock Repurchase - GlobeNewswire
SRX Global Board of Directors Authorizes Stock Repurchase Plan of Up to 10 Million Shares or Up to 50% of its Shares Outstanding - Yahoo Finance
SRX Global Reports Preliminary Net Asset Value of Approximately $3.07 Per Share and Over $55 Million in Cash and Short-Term Investments(1) - Yahoo Finance
SRX Global Reports Preliminary June 30, 2026 Balance Sheet Update, About $40 Million in Cash and No Debt Following EMJX Acquisition and Reverse Split | SRXH Stock News - Quiver Quantitative
SRX Global Declares One-Time Cash Dividend - GlobeNewswire
SRX Global Makes Strategic Investment in Critical and Precious Minerals Development Company, Greenland Mines - GlobeNewswire
SRX Global Announces Share Consolidation - Yahoo Finance
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences - GlobeNewswire
SRX Global Inc Azioni (SRXH) Dati Finanziari
Non sono disponibili dati finanziari per SRX Global Inc (SRXH). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
5.19%
3.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):